UK markets closed

Santen Pharmaceutical Co., Ltd. (4536.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
1,628.00-13.00 (-0.79%)
At close: 03:15PM JST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
26,642,000
-14,948,000
27,218,000
9,311,000
23,618,000
Depreciation & amortisation
18,178,000
17,249,000
17,055,000
17,498,000
16,573,000
Change in working capital
14,168,000
-5,059,000
1,180,000
-21,477,000
-1,976,000
Inventory
-1,369,000
-1,144,000
5,383,000
-4,590,000
-981,000
Other working capital
61,962,000
12,559,000
10,202,000
15,004,000
30,719,000
Other non-cash items
7,059,000
1,355,000
22,000
2,384,000
992,000
Net cash provided by operating activities
72,649,000
37,147,000
46,043,000
38,808,000
39,947,000
Cash flows from investing activities
Investments in property, plant and equipment
-10,687,000
-24,588,000
-35,841,000
-23,804,000
-9,228,000
Acquisitions, net
-207,000
-3,470,000
-2,969,000
-29,183,000
-
Purchases of investments
-301,000
-589,000
-1,067,000
-3,384,000
-398,000
Sales/maturities of investments
4,127,000
2,149,000
3,870,000
3,070,000
3,503,000
Other investing activities
127,000
-279,000
838,000
-54,000
948,000
Net cash used for investing activities
-6,145,000
-26,777,000
-35,169,000
-53,355,000
-5,175,000
Net change in cash
32,473,000
-26,850,000
16,432,000
-31,232,000
22,044,000
Cash at beginning of period
57,903,000
83,014,000
62,888,000
91,430,000
70,796,000
Cash at end of period
94,582,000
57,903,000
83,014,000
62,888,000
91,430,000
Free cash flow
Operating cash flow
72,649,000
37,147,000
46,043,000
38,808,000
39,947,000
Capital expenditure
-10,687,000
-24,588,000
-35,841,000
-23,804,000
-9,228,000
Free cash flow
61,962,000
12,559,000
10,202,000
15,004,000
30,719,000